J. Fourie

发表

Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy.

R. Diasio, Adam M. Lee, H. Ezzeldin, 2004, Clinical advances in hematology & oncology : H&O.

Translational neuroscience of basolateral amygdala lesions: Studies of urbach‐wiethe disease

Dan J Stein, J. Fourie, J. van Honk, 2016, Journal of neuroscience research.

Aripiprazole (Otsuka Pharmaceutical Co).

J. Fourie, F. Ozdener, V. Ozdemir, 2002, Current opinion in investigational drugs.

13C-5-FU breath test current status and future directions: a comprehensive review

R. Diasio, H. Ezzeldin, J. Fourie, 2009, Journal of breath research.

Induction of NQO1 in cancer cells.

J. Fourie, A. Begleiter, 2004, Methods in enzymology.

The Uracil Breath Test in the Assessment of Dihydropyrimidine Dehydrogenase Activity: Pharmacokinetic Relationship between Expired 13CO2 and Plasma [2-13C]Dihydrouracil

R. Diasio, J. Fourie, R. Desmond, 2006, Clinical Cancer Research.

FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation

J. Fourie, R. Pazdur, R. Justice, 2010, Oncology.

Treatment-Resistance to Clozapine in Association With Ultrarapid CYP1A2 Activity and the C → A Polymorphism in Intron 1 of the CYP1A2 Gene: Effect of Grapefruit Juice and Low-Dose Fluvoxamine

J. Fourie, A. Okey, W. Kalow, 2001, Journal of clinical psychopharmacology.

NMDA receptor antagonists to characterize rat renal organic cation transporter function.

J. Fourie, D. Sitar, M. R. Escobar, 2002, European journal of pharmacology.

Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity

Frank S. Guziec, J. Fourie, A. Begleiter, 2004, Cancer Chemotherapy and Pharmacology.

The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase

Frank S. Guziec, J. Fourie, A. Begleiter, 2002, Cancer Chemotherapy and Pharmacology.

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer

R. Diasio, J. Fourie, 2012, Drugs.

The role of Sp1 and Sp3 in the constitutive DPYD gene expression.

R. Diasio, J. Fourie, Lin Li, 2006, Biochimica et biophysica acta.

Probing peripheral and central cholinergic system responses.

C. Naranjo, N. Herrmann, J. Fourie, 2000, Journal of psychiatry & neuroscience : JPN.

Age Dependent Pupillary and Cognitive Responses to Cholinergic Drugs as a Model for Identificaton of Future Biological Markers for Alzheimer's Disease

J. Fourie, 1998 .

Pharmacokinetic Changes in the Elderly

C. Naranjo, J. Fourie, U. Busto, 1996 .

Increased Prevalence of Dihydropyrimidine Dehydrogenase Deficiency in African-Americans Compared with Caucasians

R. Diasio, J. Fourie, M. Saif, 2006, Clinical Cancer Research.

Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

C. Naranjo, J. Fourie, U. Busto, 1996, Clinical pharmacokinetics.

Dose dependent inhibition of uridine phosphorylase (UP) by eniluracil (EU): Was the clinical inferiority of the EU/5-fluorouracil (5-FU) phase III trials due to an unrecognized inhibition of 5-FU anabolism?

R. Diasio, J. Fourie, V. Guarcello, 2006, Journal of Clinical Oncology.